Pilot study for the detection of early exudative age-related macular degeneration with optical coherence tomography
L. Padnick-Silver, A.B. Weinberg, F.P. Lafranco, and M.S. Macsai Pilot study for the detection of early exudative age-related macular degeneration with optical coherence tomography Retina 32 2012 1045 1056
Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration
Macular Photocoagulation Study Group
Macular Photocoagulation Study Group Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration Arch Ophthalmol 115 1997 741 747
Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study
Macular Photocoagulation Study Group
Macular Photocoagulation Study Group Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study Arch Ophthalmol 109 1991 1242 1257
Fusion regimen: Ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity
J. Monés, M. Biarnés, F. Trindade, and R. Casaroli-Marano Fusion regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity Graefes Arch Clin Exp Ophthalmol 250 2012 1737 1744
Intravitreal ranibizumab for exudative age-related macular degeneration with good baseline visual acuity
M. Saito, T. Iida, and M. Kano Intravitreal ranibizumab for exudative age-related macular degeneration with good baseline visual acuity Retina 32 2012 1250 1259
Intravitreal bevacizumab for age-related macular degeneration with good visual acuity
M. Takahashi, T. Sato, and S. Kishi Intravitreal bevacizumab for age-related macular degeneration with good visual acuity Jpn J Ophthalmol 54 2010 565 570
Do we need a new classification for choroidal neovascularization in age-related macular degeneration?
K.B. Freund, S.A. Zweifel, and M. Engelbert Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina 30 2010 1333 1349
Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes
J.D. Gass Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes Am J Ophthalmol 118 1994 285 298
A simplified severity scale for age-related macular degeneration: AREDS report no. 18
Age-Related Eye Disease Study Research Group
Age-Related Eye Disease Study Research Group A simplified severity scale for age-related macular degeneration: AREDS report no. 18 Arch Ophthalmol 123 2005 1570 1574
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration
Comparison of Age-Related Macular Degeneration Treatments Trials Research Group
G. Ying, J. Huang, M.G. Maguire Comparison of Age-Related Macular Degeneration Treatments Trials Research Group Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration Ophthalmology 120 2013 122 129
Detection of new-onset choroidal neovascularization using optical coherence tomography: The AMD DOC Study
D.V. Do, E.W. Gower, and S.D. Cassard et al. Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study Ophthalmology 119 2012 771 778
Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal
R.N. Khurana, B. Dupas, and N.M. Bressler Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal Ophthalmology 117 2010 1376 1380